AU1031397A - Human peptide circulating in the blood and possessing insulinotropic properties - Google Patents
Human peptide circulating in the blood and possessing insulinotropic propertiesInfo
- Publication number
- AU1031397A AU1031397A AU10313/97A AU1031397A AU1031397A AU 1031397 A AU1031397 A AU 1031397A AU 10313/97 A AU10313/97 A AU 10313/97A AU 1031397 A AU1031397 A AU 1031397A AU 1031397 A AU1031397 A AU 1031397A
- Authority
- AU
- Australia
- Prior art keywords
- possessing
- blood
- human peptide
- insulinotropic properties
- peptide circulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 230000002473 insulinotropic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19543628 | 1995-11-24 | ||
DE1995143628 DE19543628A1 (en) | 1995-11-24 | 1995-11-24 | Human circulating peptide with insulinotropic activity (GCAP-II- (89-112), (guanylyl cyclase C activating peptide II) and its GCAP analogues, in particular GCAP-I- (99-115), its use as a pharmacological Active ingredient and use of its principle of action to provide new GC-C-dependent insulinotropic active ingredients |
PCT/EP1996/005183 WO1997020049A1 (en) | 1995-11-24 | 1996-11-23 | Human peptide circulating in the blood and possessing insulinotropic properties |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1031397A true AU1031397A (en) | 1997-06-19 |
Family
ID=7778185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10313/97A Abandoned AU1031397A (en) | 1995-11-24 | 1996-11-23 | Human peptide circulating in the blood and possessing insulinotropic properties |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1031397A (en) |
DE (1) | DE19543628A1 (en) |
WO (1) | WO1997020049A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001256315A1 (en) * | 2000-04-22 | 2001-11-07 | Ipf Pharmaceuticals Gmbh | Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2 |
DE10292434D2 (en) * | 2001-06-05 | 2004-07-29 | Yueksel Savas | Use of a peptide that activates guanylate cyclase C for the treatment of respiratory diseases via the airways, pharmaceuticals, inhalation device and diagnostic methods |
US7494979B2 (en) * | 2003-06-13 | 2009-02-24 | Ironwood Pharmaceuticals, Inc. | Method for treating congestive heart failure and other disorders |
CA2529307C (en) | 2003-06-13 | 2013-12-24 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US8173596B2 (en) | 2004-05-14 | 2012-05-08 | The University Of North Carolina At Chapel Hill | Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis |
US10450343B2 (en) | 2013-03-21 | 2019-10-22 | Sanofi-Aventis Deutschland Gmbh | Synthesis of cyclic imide containing peptide products |
HUE034308T2 (en) | 2013-03-21 | 2018-02-28 | Sanofi Aventis Deutschland | Synthesis of hydantoin containing peptide products |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4309815A1 (en) * | 1993-03-26 | 1994-09-29 | Forssmann Wolf Georg | Method for isolating and using guanylate cyclase-activating peptide I (GAP-I) |
WO1995003410A2 (en) * | 1993-07-20 | 1995-02-02 | Forssmann Wolf Georg | Guanylatcyclase activating peptide i (gcap-i) coding gene |
US5489670A (en) * | 1993-10-29 | 1996-02-06 | G. D. Searle & Co. | Human uroguanylin |
-
1995
- 1995-11-24 DE DE1995143628 patent/DE19543628A1/en not_active Withdrawn
-
1996
- 1996-11-23 AU AU10313/97A patent/AU1031397A/en not_active Abandoned
- 1996-11-23 WO PCT/EP1996/005183 patent/WO1997020049A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997020049A1 (en) | 1997-06-05 |
DE19543628A1 (en) | 1997-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7230196A (en) | Pskh-1 ribozymes and uses in disease treatment | |
AU5687896A (en) | Use of alpha 1L-agonists in the treatment of incontinence | |
AU2655599A (en) | Endoluminal implant with therapeutic and diagnostic capability | |
EP0795007A4 (en) | Bioengineered human blood cells | |
AU3955795A (en) | Biocompatible coating, medical device using the same and methods | |
IL118442A0 (en) | Triazolymethyl-cyclopentanols their preparation and use | |
AU7319994A (en) | Nucleotide preparation and uses thereof in wound healing | |
IL118441A0 (en) | Triazolymethyl-oxiranes their preparation and use | |
GB2304309B (en) | Laminate and use thereof | |
HK1010153A1 (en) | Recombinant human alpha-fetoprotein and uses thereof. | |
AU4131597A (en) | Sulfated polysaccharides and uses thereof in medical treatment | |
AU3099997A (en) | The use of tcet in the prophylaxis and treatment of allergies | |
GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
AU1031397A (en) | Human peptide circulating in the blood and possessing insulinotropic properties | |
AU4762893A (en) | Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases. | |
AU6761294A (en) | Cell surface protein expressed on human cortical thymocyte and their use | |
AU3634595A (en) | Bis-oxazolidines and their use | |
AU6525096A (en) | Modified human chorionic (beta-hcg) proteins and their medical use | |
AU6693996A (en) | Human chitinase alpha and chitinase alpha-2 | |
AU3116697A (en) | Human interleukin-1j and antagonists thereof | |
IL116658A0 (en) | Peptides their preparation and use | |
AU1800195A (en) | Durable patient chair | |
EP0841393A4 (en) | HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME | |
AU7352396A (en) | Use of protein S-100b in medicines and medicines containing the protein S-100-b | |
IL122686A0 (en) | Benzylhydroxylamines their preparation and use |